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bolesti. U oba slučaja, isključeni su drugi mogući 
uzroci akutnog pankreatitisa. Budući da je AP čest 
poremećaj, a konzumacija marihuane raširena po 
cijelom svijetu, nužno je u svih bolesnika s neja-
snom etiologijom AP-a razmišljati i o ovom, ne 
tako rijetkom uzroku AP-a. 
Ključne riječi: česta bolest, tetrahidrokanabino-
la (THC), etiologija.
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ABSTRACT
Although celiac disease (CD) may occur in pati-
ents with other immune-mediated disorders, its 
coexistence with multiple autoimmune diseases 
is not frequently described. We report the case 
of a 23-year-old woman referred to our centre 
because of jaundice and diarrhoea, who was dia-
gnosed with CD in childhood. She complied with 
a gluten-free diet until puberty. Laboratory tests 
and liver biopsy were performed to establish the 
diagnosis of autoimmune hepatitis. Her thyro-
id-specific peroxides levels and thyroid gland 
function tests were altered as well, indicating 
the presence of an autoimmune disorder of the 
thyroid gland. Immunosuppressive treatment led 
to normalization of transaminases levels and bili-
rubin. In conclusion, other autoimmune diseases 
should be ruled out in patients with CD. 
Key words: multiple autoimmune diseases, glu-
ten-free, diet
INTRODUCTION
Coeliac disease (CD) is a chronic, multifactorial, 
auto-immune disorder of the small intestine (1). 
The disease develops in genetically-predetermi-
ned individuals because of persistent intolerance of 
gluten (1,2). Patients with CD may present to spe-
cialists other than gastroenterologists with diverse 
clinical manifestations (1-3). Here we report a case 
of a 23-year-old patient with previously diagnosed 
CD, with multiple autoimmune diseases. 
CASE REPORT
In August 2010, a 23-year-old woman was ad-
mitted to our department after experiencing diar-
rhoea, jaundice and weight loss that had occurred 
during the past 14 days. Her medical history be-
gan in 1990, when she was diagnosed with CD. 
She complied with a gluten-free diet (GFD) until 
puberty. She reported that her father was also di-
agnosed with CD. 
Our patient gave birth six months prior to admi-
ssion. Results of her physical examination iden-
tified a heart rate of 120 beats/min, jaundice, an 
enlarged thyroid gland, and hepatomegaly. The 
laboratory evaluation showed a serum Hb of 113 
g/L (normal 119–157 g/L), iron 39 µmol/L (nor-
mal 8–30 µmol/L), ferritin 459 µg/L (normal 
10–120 µg/L), MCV 75.4 f/L (normal 83–97 
f/L), reticulocytes 138 x 109/L (normal 22–97 
x 10 9/L). Serum AST and ALT levels were 924 
U/L (normal 8–30 U/L) and 1181 U/L (normal 
10–36 U/L), respectively, with an ALP level of 
168 U/L (normal 64–153 U/L) and bilirubin le-
vel of 311 µmol/L (normal 3–20 µmol/L), with 
non-significant unconjugated hyperbilirubinae-
mia. Prothrombin time (PT) was 60% (normal 
>70%). Serum albumin, gamma globulins, and 
gamma glutamyl transferase (gGT) were within 
normal limits. Coombs direct and indirect tests 
were both negative. Screening evaluations for 
viral, autoimmune, and metabolic etiologies for 
chronic liver disease were unremarkable, except 
for an elevated anti-nuclear antibody (ANA). 
Anti-tTG antibodies were elevated to 226 RU/
ml (normal < 20 RU/ml). Abdominal ultraso-
und showed hepatosplenomegaly, whereas there 
were no signs of biliary obstruction. 
Because of the suggestive laboratory data, a 
diagnosis of autoimmune hepatitis (AIH) was 
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or if it changes the natural history of the disease 
(1,2). Vljamaa et al (2) showed that a GFD does 
not reduce the risk of autoimmune diseases and 
has a negligible impact on the outcome of these 
diseases, whereas Ventura et al (3) showed that 
autoimmune diseases are more common in CD 
patients without GFD than in the control group 
(14% vs. 2.8%), and the risk increases with the 
duration of gluten exposure. Several CD-asso-
ciated disorders might improve on GFD such as 
neurological, cardiac, and renal diseases, whe-
reas the effect of GFD on the course of autoi-
mmune liver disorders (AILD) requires further 
investigation (4,5). Furthermore, only few stu-
dies have investigated the role of GFD on the 
course of AILD. Some studies reported that with 
diet compliance, AILD may regress or go into 
remission, whereas some studies do not support 
such a hypothesis (6). In our case, it is doubtful 
whether non-compliance with GFD contributed 
to the development of autoimmune diseases of 
the liver and thyroid.  Forty percent of patients 
with CD have reactive hepatitis with mild dis-
turbance of liver function characterized by rai-
sed hepatic transaminase enzymes, with normal 
GGT and serum bilirubin levels (5-9).  This con-
dition is usually marked as “coeliac hepatitis” 
(1,9). This is explained by an increased perme-
ability of the intestinal wall and increased avai-
lability of different antigens, toxins, and inflam-
matory mediators in the portal circulation (5-9). 
Pathological changes are mild and non-specific, 
and patients generally have no symptoms of li-
ver damage or have nonspecific symptoms like 
fatigue and malaise (4,5). Transaminase levels 
usually return to normal in 95% of cases within 
12 months after GFD (6-9). But, it is necessary 
to exclude other causes of liver damage, such 
as AILD in patients with persistently elevated 
transaminases who comply with GFD (4-9). 
In our case report, we describe the association 
between CD and autoimmune hepatitis (AIH) 
type I. In patients with CD, the prevalence of 
AIH is approximately 4%, and is most frequently 
AIH type II (4,5). When both diseases are pre-
sent, AIH is more often diagnosed first and CD is 
usually latent (4-9). The clinical impact of GFD 
on the outcome of AIH remains to be elucidated 
(6,10). People with CD also have an increased 
risk of developing autoimmune thyroid disease 
considered, and a liver biopsy was performed. 
Histological findings were compatible with 
AIH (Figure 1) which, together with positi-
ve ANA antibodies, suggested type I autoim-
mune hepatitis. Furthermore, high titers of se-
rum TPO antibodies were presented with high 
values of thyroid hormones, and a diagnosis 
of autoimmune thyroid disease (ATD) with 
hyperthyroidism was assumed. The patient was 
advised to follow GFD and was started on an 
immunosuppressive treatment (an initial dose 
of prednisone 30 mg) with tiamazol. The pati-
ent responded well and her transaminases and 
bilirubin levels returned to normal, as well as 
thyroid gland function tests and anti-tTG anti-
body titers. Continued further ambulatory mo-
nitoring by a gastroenterologist and an endocri-
nologist was advised.
Gastroenterologists are familiar with the asso-
ciation between CD and immune and non-im-
mune diseases (1,2). However, many diseases 
outside of the digestive system are also linked 
with CD, and patients with CD have about a 
ten-fold greater risk of other autoimmune di-
seases than the general population (1-3). When 
both autoimmune diseases and CD occur, CD is 
usually silent; as a result, the autoimmune disor-
der is frequently diagnosed first (1). Our patient 
was first diagnosed with CD, presenting with 
typical CD features, whereas both autoimmune 
disorders occurred nineteen years later. It is not 
known whether the treatment of CD reduces the 
likelihood of developing autoimmune disorders, 
Figure 1. Pathohistological findings of liver biopsy. The lobular 
architecture of the liver is compromised. Streaks of connective 
tissue are visible, which deform the liver parenchyma in sev-
eral places. Predominantly lymphocytic inflammatory infiltrate 
is visible in the relatively wide connective tissue streaks, but 
plasma cells are also present, the finding that suggests auto-
immune hepatitis (Milić S, 2010)
Medicinski Glasnik, Volume 10, Number 2, August 2013
410
(ATD) (1,5). According to the available literatu-
re, 2% to 7.8 % of CD patients may develop some 
form of ATD (1,5). This association is primarily 
explained by a common genetic predisposition 
(1,5). In our patient, symptoms of hyperthyroi-
dism (weight loss and tachycardia) were present, 
with elevated levels of FT3 and FT4, decreased 
levels of TSH, and high titers of thyroglobulin 
antibodies. We started therapy with tiamazol and 
beta adrenergic receptor blocker, with further 
outpatient monitoring by an endocrinologist. 
Both autoimmune disorders developed in our 
patient after non-compliance with GFD. It is 
doubtful whether our patient’s non-compliance 
with GFD contributed to the development of au-
toimmune diseases of the liver and thyroid. We 
would like to stress the necessity of an interdis-
ciplinary approach to patients with CD as well 
as many other conditions.
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SAŽETAK 
Iako celijakija ili glutenska enteropatija može 
biti udružena s drugim imunološkim bolestima, 
udruženost celijakije s više autoimunih bolesti 
nije česta. U ovom radu prikazujemo slučaj 23-
godišnje bolesnice, liječene u našem Centru zbog 
ikterusa i proljeva, a kojoj je dijagnoza celijakije 
postavljena još u djetinjstvu. Do početka puber-
teta pacijentica se pridržavala bezglutenske dije-
te. Tijekom boravka u našem Centru, učinjenom 
dijagnostičkom obradom (laboratorijski pokaza-
telji i patohistološki nalaz bioptata jetre), doka-
zan je autoimuni hepatitis. Nadalje, funkcionalni 
testovi štitnjače, kao i pozitivan nalaz antitijela 
na tkivnu peroksidazu, ukazivali su na autoimunu 
bolest štitnjače. Primjenom imunosupresivne te-
rapije došlo je do normalizacije vrijednosti ami-
notransferaza, kao i regresije ikterusa. Slijedom 
navedenog, u bolesnika s celijakijom nužno je 
razmišljati i o drugim imunološkim bolestima.
Ključne riječi: imunološke bolesti, bezgluten-
ska, dijeta
